Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Telmisartan 40mg and Hydrochlorothiazide 25mg Monotherapy in High Sodium Intake Patients With Mild to Moderate Hypertension: a Multicenter Randomized Double-blinded Parallel Controlled Trial

NCT02255253 is registered in ClinicalTrials.gov with The George Institute for Global Health, China as lead sponsor.

NCT NCT02255253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02255253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Telmisartan 40mg and Hydrochlorothiazide 25mg Monotherapy in High Sodium Intake Patients With Mild to Moderate Hypertension: a Multicenter Randomized Double-blinded Parallel Controlled Trial
Lead sponsor
The George Institute for Global Health, China
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
March 31, 2015
Enrollment
1,410 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension